chr10-91864915-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_025235.4(TNKS2):c.*1916G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 152,518 control chromosomes in the GnomAD database, including 1,582 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1576 hom., cov: 32)
Exomes 𝑓: 0.16 ( 6 hom. )
Consequence
TNKS2
NM_025235.4 3_prime_UTR
NM_025235.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.211
Genes affected
TNKS2 (HGNC:15677): (tankyrase 2) Enables NAD+ ADP-ribosyltransferase activity; enzyme binding activity; and protein ADP-ribosylase activity. Involved in several processes, including protein ADP-ribosylation; protein localization to chromosome, telomeric region; and regulation of telomere maintenance. Located in nuclear envelope; pericentriolar material; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.15 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNKS2 | NM_025235.4 | c.*1916G>A | 3_prime_UTR_variant | 27/27 | ENST00000371627.5 | ||
TNKS2 | XM_011540213.2 | c.*1916G>A | 3_prime_UTR_variant | 27/27 | |||
TNKS2 | XM_017016699.2 | c.*1916G>A | 3_prime_UTR_variant | 26/26 | |||
TNKS2 | XM_017016700.3 | c.*1916G>A | 3_prime_UTR_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNKS2 | ENST00000371627.5 | c.*1916G>A | 3_prime_UTR_variant | 27/27 | 1 | NM_025235.4 | P1 | ||
TNKS2 | ENST00000710380.1 | c.*1916G>A | 3_prime_UTR_variant | 27/27 |
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21181AN: 151968Hom.: 1574 Cov.: 32
GnomAD3 genomes
AF:
AC:
21181
AN:
151968
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.155 AC: 67AN: 432Hom.: 6 Cov.: 0 AF XY: 0.169 AC XY: 44AN XY: 260
GnomAD4 exome
AF:
AC:
67
AN:
432
Hom.:
Cov.:
0
AF XY:
AC XY:
44
AN XY:
260
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.139 AC: 21207AN: 152086Hom.: 1576 Cov.: 32 AF XY: 0.137 AC XY: 10160AN XY: 74366
GnomAD4 genome
AF:
AC:
21207
AN:
152086
Hom.:
Cov.:
32
AF XY:
AC XY:
10160
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
302
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at